It has been demonstrated that quercetin (3,3',4',5,7-pentahydroxyflavone) inhibits the growth of several cancer cell lines and that the antiproliferative activity of this substance is probably mediated through a binding interaction with type II estrogen binding sites (type II EBS). The effect of quercetin and cytosine arabinoside (Ara-C) alone or in combination, was tested on HL-60 cell growth. Quercetin significantly synergized the inhibitory activity of Ara-C on HL-60 cell growth while rutin, the 3-rhamnosylglucoside of quercetin, neither competed with [3H]estradiol for type II EBS nor was effective alone or in combination with Ara-C. Based on these results, we studied by a clonogenic assay the effect of quercetin and Ara-C alone and in combination on colony formation by human leukemic cells (CFU-L). In all cases both drugs exhibited a dose-related inhibition of CFU-L in a range of concentrations between 10 nM and 10 microM and 0.01 nM and 10 microM for quercetin and Ara-C, respectively. The combination of the two drugs resulted in a synergistic inhibitory activity on CFU-L. Considering that plasma concentrations of quercetin effective in vitro were obtained in vivo without any apparent side effects, we conclude that this report represents further experimental evidence that quercetin could be used in the treatment of acute leukemias.

The combination of quercetin and cytosine arabinoside synergistically inhibits leukemic cell growth / Luciana, Teofili; Pierelli, Luca; M., Stefania Iovino; Giuseppe, Leone; Giovanni, Scambia; Rosa De, Vincenzo; BENEDETTI PANICI, Pierluigi; Giacomo, Menichella; E., Macr; Mauro, Piantelli; Franco O., Ranelletti; Luigi M., Larocca. - In: LEUKEMIA RESEARCH. - ISSN 0145-2126. - 16:5(1992), pp. 497-503. [10.1016/0145-2126(92)90176-8]

The combination of quercetin and cytosine arabinoside synergistically inhibits leukemic cell growth.

PIERELLI, LUCA;BENEDETTI PANICI, PIERLUIGI;
1992

Abstract

It has been demonstrated that quercetin (3,3',4',5,7-pentahydroxyflavone) inhibits the growth of several cancer cell lines and that the antiproliferative activity of this substance is probably mediated through a binding interaction with type II estrogen binding sites (type II EBS). The effect of quercetin and cytosine arabinoside (Ara-C) alone or in combination, was tested on HL-60 cell growth. Quercetin significantly synergized the inhibitory activity of Ara-C on HL-60 cell growth while rutin, the 3-rhamnosylglucoside of quercetin, neither competed with [3H]estradiol for type II EBS nor was effective alone or in combination with Ara-C. Based on these results, we studied by a clonogenic assay the effect of quercetin and Ara-C alone and in combination on colony formation by human leukemic cells (CFU-L). In all cases both drugs exhibited a dose-related inhibition of CFU-L in a range of concentrations between 10 nM and 10 microM and 0.01 nM and 10 microM for quercetin and Ara-C, respectively. The combination of the two drugs resulted in a synergistic inhibitory activity on CFU-L. Considering that plasma concentrations of quercetin effective in vitro were obtained in vivo without any apparent side effects, we conclude that this report represents further experimental evidence that quercetin could be used in the treatment of acute leukemias.
1992
precursor cell lymphoblastic leukemia-lymphoma; promyelocytic; tumor stem cell assay; acute; quercetin; leukemia; synergism; metabolism/pharmacology; myeloid; type ii estrogen binding site; ara-c; cytarabine; drug synergism; estrogen; metabolism; colony formation inhibitors; humans; receptors; drug effects; hl-60 cell line; type-ii estrogen binding site; metabolism/pathology; cell division; tumor cells; cultured; acute disease; human leukemic cells
01 Pubblicazione su rivista::01a Articolo in rivista
The combination of quercetin and cytosine arabinoside synergistically inhibits leukemic cell growth / Luciana, Teofili; Pierelli, Luca; M., Stefania Iovino; Giuseppe, Leone; Giovanni, Scambia; Rosa De, Vincenzo; BENEDETTI PANICI, Pierluigi; Giacomo, Menichella; E., Macr; Mauro, Piantelli; Franco O., Ranelletti; Luigi M., Larocca. - In: LEUKEMIA RESEARCH. - ISSN 0145-2126. - 16:5(1992), pp. 497-503. [10.1016/0145-2126(92)90176-8]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/435985
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 57
  • ???jsp.display-item.citation.isi??? 55
social impact